Do the socioeconomic impacts of antiretroviral therapy vary by gender? A longitudinal study of Kenyan agricultural worker employment outcomes

Larson, Bruce A.; Fox, Mathew P.; Rosen, Sydney; Bii, Margret; Sigei, Carolyne; Shaffer, Douglas; Sawe, Fredrick; McCoy, Kelly; Wasunna, Monique; Simon, Jonathan L.
January 2009
BMC Public Health;2009, Vol. 9 Issue 1, p240
Academic Journal
Background: As access to antiretroviral therapy (ART) has grown in Africa, attention has turned to evaluating the socio-economic impacts of ART. One key issue is the extent to which improvements in health resulting from ART allows individuals to return to work and earn income. Improvements in health from ART may also be associated with reduced impaired presenteeism, which is the loss of productivity when an ill or disabled individual attends work but accomplishes less at his or her usual tasks or shifts to other, possibly less valuable, tasks. Methods: Longitudinal data for this analysis come from company payroll records for 97 HIV-infected tea estate workers (the index group, 56 women, 41 men) and a comparison group of all workers assigned to the same work teams (n = 2485, 1691 men, 794 women) for a 37-month period covering two years before and one year after initiating ART. We used nearest neighbour matching methods to estimate the impacts of HIV/AIDS and ART on three monthly employment outcomes for tea estate workers in Kenya - days plucking tea, days assigned to non-plucking assignments, and kilograms harvested when plucking. Results: The female index group worked 30% fewer days plucking tea monthly than the matched female comparison group during the final 9 months pre-ART. They also worked 87% more days on non-plucking assignments. While the monthly gap between the two groups narrowed after beginning ART, the female index group worked 30% fewer days plucking tea and about 100% more days on non-plucking tasks than the comparison group after one year on ART. The male index group was able to maintain a similar pattern of work as their comparison group except during the initial five months on therapy. Conclusion: Significant impaired presenteeism continued to exist among the female index group after one year on ART. Future research needs to explore further the socio-economic implications of HIV-infected female workers on ART being less productive than the general female workforce over sustained periods of time.


Related Articles

  • Adherence to anti-retroviral prophylaxis after occupational and non-occupational exposure to human immunodeficiency virus in patients consulting the Voluntary Counseling and Testing center of Imam Khomeini Hospital, Tehran, 2008-2009. azar Hadadi; Mehrnaz Rasoulinezhad; Saeed Jamali; Seyed Ahmad Seyed Ali naghi; Kousha Paydari; Mohammad Ali Boyer; Esfandiar Shojaie; Alireza Soleymani; Sirous Faraji; Saeed Kalantari; Samaneh Bayrami; Mostafa Hosseini // Journal of School of Public Health & Institute of Public Health ;2012, Vol. 9 Issue 3, p1 

    Background and Aim: The aim of this study was to assess the adherence to anti-retroviral prophylaxis after occupational and non-occupational exposure to human immunodeficiency virus (HIV) in patients consulting the Voluntary Counseling and Testing Center (VCT) of Imam Khomeini Hospital, Tehran...

  • ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia. Maldarelli, Frank; Palmer, Sarah; King, Martin S.; Wiegand, Ann; Polis, Michael A.; Mican, JoAnn; Kovacs, Joseph A.; Davey, Richard T.; Rock-Kress, Diane; Dewar, Robin; Shuying Liu; Metcalf, Julia A.; Rehm, Catherine; Brun, Scott C.; Hanna, George J.; Kempf, Dale J.; Coffin, John M.; Mellors, John W. // PLoS Pathogens;Apr2007, Vol. 3 Issue 4, pe46 

    Current antiretroviral therapy is effective in suppressing but not eliminating HIV-1 infection. Understanding the source of viral persistence is essential for developing strategies to eradicate HIV-1 infection. We therefore investigated the level of plasma HIV-1 RNA in patients with viremia...

  • Early Adherence to Antiretroviral Medication as a Predictor of Long-Term HIV Virological Suppression: Five-Year Follow Up of an Observational Cohort. Ford, Nathan; Darder, Marta; Spelman, Tim; Maclean, Emi; Mills, Edward; Boulle, Andrew // PLoS ONE;2010, Vol. 5 Issue 5, p1 

    Objective: Previous studies have demonstrated a cross-sectional relationship between antiretroviral adherence and HIV virological suppression. We assessed the predictive value of baseline adherence in determining long-term virological failure. Design: We assessed baseline adherence via an...

  • Whole-Blood Interleukin-18 Level during Early HIV-1 Infection Is Associated with Reduced CXCR4 Coreceptor Expression and Interferon-γ Levels. Sailer, Carrie A.; Pott, Gregory B.; Dinarello, Charles A.; Ma Whinney, Samantha; Forster, Jeri E.; Larson-Duran, Jacqueline K.; Landay, Alan; Al-Harthi, Lena; Schooley, Robert T.; Benson, Constance A.; Judson, Franklyn N.; Thompson, Melanie; Palella, Frank J.; Shapiro, Leland // Journal of Infectious Diseases;3/1/2007, Vol. 195 Issue 5, p734 

    Interleukin (IL)-18 generates T helper 1-type immunity and inhibits human immunodeficiency virus type 1 (HIV-1) in primary cells in vitro. Because IL-18 may participate in HIV-1 containment, whole-blood IL-18 levels were measured in 20 healthy control subjects and longitudinally in 28 subjects...

  • Mozambique issues compulsory license for HIV antiretrovirals.  // WHO Drug Information;2004, Vol. 18 Issue 2, p141 

    The HIV/AIDS pandemic constitutes a serious handicap in Mozambique's struggle against hunger, illness, underdevelopment and misery. High rates of morbidity and mortality have put Mozambique among the ten countries in Africa worst hit by HIV. Antiretroviral drugs are available which prolong the...

  • Highly Active Antiretroviral Therapy and Viral Response in HIV Type 2 Infection. Mullins, Christopher; Eisen, Geoffrey; Popper, Stephen; Dieng Sarr, Abdoulaye; Sankalé, Jean-Louis; Berger, Judith J.; Wright, Sharon B.; Chang, Hernan R.; Coste, Gérard; Cooley, Timothy P.; Rice, Peter; Skolnik, Paul R.; Sullivan, Margaret; Kanki, Phyllis J. // Clinical Infectious Diseases;6/15/2004, Vol. 38 Issue 12, p1771 

    Human immunodeficiency virus type 2 (HIV-2), the second human retrovirus known to cause AIDS, is endemic to West Africa but is infrequently found outside this region. We present a case series of 10 HIV-2-infected individuals treated in the United States. Physicians applied the principles of...

  • The burden of pediatric HIV/AIDS in Constanta, Romania: a cross-sectional study. Kozinetz, Claudia A.; Matusa, Rodica; Cazacu, Andreaa; Kozinetz, C A; Matusa, R; Cazacu, A // BMC Infectious Diseases;2001, Vol. 1 Issue 1, p7 

    Background: By 1990, 94 percent of the acquired immunodeficiency syndrome (AIDS) cases in Romania were in children less than 13 years of age. The majority of the cases were identified in the city of Constanta. The purpose of this paper was to describe the current burden of pediatric...

  • Recurrent HIV-1 Integration at the BACH2 Locus in Resting CD4+ T Cell Populations during Effective Highly Active Antiretroviral Therapy. Ikeda, Terumasa; Shibata, Junji; Yoshimura, Kazuhisa; Koito, Atsushi; Matsushita, Shuzo // Journal of Infectious Diseases;3/1/2007, Vol. 195 Issue 5, p716 

    The persistence of latent human immunodeficiency virus type 1 (HIV-1) has been considered one of the major obstacles for eradication of the virus in infected individuals receiving successful antiretroviral therapy. To determine the contribution of integration sites to viral latency within...

  • Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan Africa. Sigaloff, Kim C. E.; Hamers, Raph L.; Wallis, Carole L; Kityo, Cissy; Siwale, Margaret; Ive, Prudence; Botes, Mariette E.; Mandaliya, Kishor; Wellington, Maureen; Osibogun, Akin; Stevens, Wendy S.; van Vugt, Michèle; Rinke de Wit, Tobias F. // Journal of Infectious Diseases;Jun2012, Vol. 205 Issue 11, p1739 

    Little is known about the effect of human immunodeficiency virus type 1 (HIV-1) resistance mutations present at time of regimen switch on the response to second-line antiretroviral therapy in Africa. In adults who switched to boosted protease inhibitor-based regimens after first-line failure,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics